HEADER HYDROLASE 07-MAR-23 8GEN TITLE E. ELIGENS BETA-GLUCURONIDASE BOUND TO UNC10201652-GLUCURONIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-GLUCURONIDASE; COMPND 3 CHAIN: A; COMPND 4 EC: 3.2.1.31; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LACHNOSPIRA ELIGENS; SOURCE 3 ORGANISM_TAXID: 39485; SOURCE 4 GENE: UIDA, ERS852490_00568, ERS852492_02599; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BETA-GLUCURONIDASE, INHIBITOR, GLUCURONIDE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.B.SIMPSON,M.R.REDINBO REVDAT 1 14-FEB-24 8GEN 0 JRNL AUTH J.B.SIMPSON,M.R.REDINBO JRNL TITL DIVERSE HUMAN THERAPEUTICS IMPACT HORMONE AND JRNL TITL 2 NEUROTRANSMITTER HOMEOSTASIS BY INHIBITING GUT MICROBIAL JRNL TITL 3 ENZYMES JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.50 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 3 NUMBER OF REFLECTIONS : 25955 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.251 REMARK 3 R VALUE (WORKING SET) : 0.249 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.710 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.5000 - 7.0800 0.90 1796 149 0.2137 0.2317 REMARK 3 2 7.0800 - 5.6200 0.92 1729 146 0.2398 0.2598 REMARK 3 3 5.6200 - 4.9100 0.94 1749 145 0.2189 0.2257 REMARK 3 4 4.9100 - 4.4600 0.93 1692 142 0.2161 0.2808 REMARK 3 5 4.4600 - 4.1400 0.94 1715 143 0.2281 0.2441 REMARK 3 6 4.1400 - 3.9000 0.95 1734 144 0.2203 0.2486 REMARK 3 7 3.9000 - 3.7000 0.95 1706 143 0.2698 0.2903 REMARK 3 8 3.7000 - 3.5400 0.95 1714 143 0.2714 0.3051 REMARK 3 9 3.5400 - 3.4100 0.95 1707 143 0.2761 0.3354 REMARK 3 10 3.4100 - 3.2900 0.95 1703 142 0.2977 0.3272 REMARK 3 11 3.2900 - 3.1900 0.95 1707 142 0.3036 0.3767 REMARK 3 12 3.1900 - 3.1000 0.95 1698 142 0.3543 0.3776 REMARK 3 13 3.1000 - 3.0100 0.94 1705 142 0.3962 0.4228 REMARK 3 14 3.0100 - 2.9400 0.90 1600 134 0.4518 0.4778 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.533 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.252 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 86.82 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 79.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 4771 REMARK 3 ANGLE : 0.843 6492 REMARK 3 CHIRALITY : 0.051 695 REMARK 3 PLANARITY : 0.005 841 REMARK 3 DIHEDRAL : 18.478 1702 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8GEN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1000272576. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-AUG-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25959 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.940 REMARK 200 RESOLUTION RANGE LOW (A) : 48.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.15470 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.8300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.8 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 1.87400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.160 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 72.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.07 M BICINE, PH 9.0, 1.4 % (W/V) 1,4 REMARK 280 -DIOXANE, 7 % (W/V) PEG 20,000, AND 30 % (V/V) GLYCEROL, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 64 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+1/3 REMARK 290 6555 X-Y,X,Z+2/3 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+1/3 REMARK 290 11555 -X+Y,Y,-Z REMARK 290 12555 X,X-Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.52200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 89.04400 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 44.52200 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 89.04400 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 44.52200 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 89.04400 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 44.52200 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 89.04400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15500 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 75320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -102.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 90.15200 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 -156.14784 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 -44.52200 REMARK 350 BIOMT1 4 0.500000 0.866025 0.000000 90.15200 REMARK 350 BIOMT2 4 0.866025 -0.500000 0.000000 -156.14784 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 -44.52200 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A -2 REMARK 465 ALA A 147 REMARK 465 ASN A 148 REMARK 465 MET A 149 REMARK 465 MET A 150 REMARK 465 SER A 151 REMARK 465 GLY A 152 REMARK 465 MET A 153 REMARK 465 MET A 154 REMARK 465 GLY A 155 REMARK 465 GLY A 156 REMARK 465 MET A 157 REMARK 465 GLY A 158 REMARK 465 ALA A 159 REMARK 465 GLY A 160 REMARK 465 ALA A 161 REMARK 465 GLY A 221 REMARK 465 LYS A 222 REMARK 465 ASP A 223 REMARK 465 TYR A 224 REMARK 465 ILE A 227 REMARK 465 GLY A 375 REMARK 465 GLY A 376 REMARK 465 GLY A 377 REMARK 465 ALA A 378 REMARK 465 ASN A 379 REMARK 465 PHE A 380 REMARK 465 GLY A 381 REMARK 465 GLY A 382 REMARK 465 GLU A 383 REMARK 465 THR A 610 REMARK 465 LYS A 611 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 8 CG CD OE1 NE2 REMARK 470 LEU A 12 CG CD1 CD2 REMARK 470 LYS A 27 CG CD CE NZ REMARK 470 LYS A 32 CG CD CE NZ REMARK 470 LYS A 39 CG CD CE NZ REMARK 470 ASP A 40 CG OD1 OD2 REMARK 470 THR A 43 OG1 CG2 REMARK 470 LYS A 101 CG CD CE NZ REMARK 470 LEU A 102 CG CD1 CD2 REMARK 470 ILE A 103 CG1 CG2 CD1 REMARK 470 GLN A 122 CG CD OE1 NE2 REMARK 470 SER A 162 OG REMARK 470 LYS A 164 CG CD CE NZ REMARK 470 GLU A 190 CG CD OE1 OE2 REMARK 470 LYS A 206 CG CD CE NZ REMARK 470 GLU A 207 CG CD OE1 OE2 REMARK 470 GLU A 208 CG CD OE1 OE2 REMARK 470 TYR A 215 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASN A 216 CG OD1 ND2 REMARK 470 LYS A 220 CG CD CE NZ REMARK 470 LYS A 230 CG CD CE NZ REMARK 470 GLU A 245 CG CD OE1 OE2 REMARK 470 GLU A 248 CG CD OE1 OE2 REMARK 470 ILE A 253 CG1 CG2 CD1 REMARK 470 GLN A 275 CG CD OE1 NE2 REMARK 470 ARG A 384 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 609 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 10 -155.34 -92.20 REMARK 500 LEU A 12 126.23 -172.46 REMARK 500 PRO A 37 -173.38 -68.26 REMARK 500 ALA A 48 140.80 178.15 REMARK 500 SER A 80 -55.46 -26.46 REMARK 500 ALA A 89 97.23 179.15 REMARK 500 HIS A 92 -125.17 70.06 REMARK 500 ASN A 99 -6.38 64.25 REMARK 500 PHE A 113 141.48 -171.95 REMARK 500 ASP A 137 -156.56 -150.42 REMARK 500 LYS A 164 147.30 65.97 REMARK 500 ASN A 175 68.77 -104.43 REMARK 500 ASP A 195 124.40 -173.98 REMARK 500 THR A 197 99.15 -167.09 REMARK 500 ASP A 203 73.45 -102.31 REMARK 500 PHE A 204 4.10 -62.55 REMARK 500 ASN A 216 70.89 -165.73 REMARK 500 LYS A 230 139.61 -173.82 REMARK 500 GLU A 248 70.71 -155.81 REMARK 500 PHE A 251 81.83 -156.69 REMARK 500 ASN A 255 77.62 43.45 REMARK 500 ASN A 263 70.21 -159.18 REMARK 500 LYS A 308 -166.91 -128.18 REMARK 500 HIS A 335 50.23 71.70 REMARK 500 ASN A 337 -26.18 -142.66 REMARK 500 PHE A 339 134.35 -175.97 REMARK 500 SER A 342 -114.49 54.46 REMARK 500 HIS A 343 42.11 -148.40 REMARK 500 TYR A 344 158.59 174.46 REMARK 500 VAL A 370 49.88 -81.62 REMARK 500 GLN A 373 47.69 -84.33 REMARK 500 HIS A 392 64.96 -112.64 REMARK 500 ASN A 479 72.90 -113.33 REMARK 500 TRP A 484 -94.34 -114.55 REMARK 500 GLU A 516 111.96 -165.02 REMARK 500 TYR A 533 -5.72 91.31 REMARK 500 THR A 568 -169.71 -120.25 REMARK 500 ARG A 587 30.75 75.78 REMARK 500 TYR A 608 5.34 -64.74 REMARK 500 REMARK 500 REMARK: NULL DBREF1 8GEN A 1 611 UNP A0A174ZZA3_9FIRM DBREF2 8GEN A A0A174ZZA3 1 611 SEQADV 8GEN SER A -2 UNP A0A174ZZA EXPRESSION TAG SEQADV 8GEN ASN A -1 UNP A0A174ZZA EXPRESSION TAG SEQADV 8GEN ALA A 0 UNP A0A174ZZA EXPRESSION TAG SEQADV 8GEN ASP A 120 UNP A0A174ZZA HIS 120 CONFLICT SEQRES 1 A 614 SER ASN ALA MET LEU TYR PRO VAL LEU THR GLN SER ARG SEQRES 2 A 614 LEU LEU SER ASP LEU SER GLY VAL TRP ASN PHE LYS LEU SEQRES 3 A 614 ASP ASN GLY LYS GLY PHE GLU GLU LYS TRP TYR GLU LYS SEQRES 4 A 614 PRO LEU LYS ASP ALA ASP THR MET PRO VAL PRO ALA SER SEQRES 5 A 614 TYR ASN ASP LEU LYS GLU GLY THR ASP PHE ARG ASP HIS SEQRES 6 A 614 TYR GLY TRP VAL PHE TYR GLN ARG ASN ILE SER VAL PRO SEQRES 7 A 614 GLU TYR VAL LYS SER GLN ARG ILE VAL LEU ARG CYS ALA SEQRES 8 A 614 ALA VAL THR HIS TYR ALA MET ILE TYR LEU ASN GLY LYS SEQRES 9 A 614 LEU ILE CYS GLU HIS LYS GLY GLY PHE LEU PRO PHE GLU SEQRES 10 A 614 VAL GLU LEU ASN ASP ASP LEU GLN ASP GLY ASP ASN LEU SEQRES 11 A 614 LEU THR ILE ALA VAL ASN ASN VAL ILE ASP TYR THR THR SEQRES 12 A 614 LEU PRO VAL GLY GLY LYS ALA ASN MET MET SER GLY MET SEQRES 13 A 614 MET GLY GLY MET GLY ALA GLY ALA SER ASP LYS PRO GLN SEQRES 14 A 614 ASN ASN PRO ASN PHE ASP PHE PHE ASN TYR CYS GLY ILE SEQRES 15 A 614 THR ARG PRO VAL LYS ILE TYR THR THR PRO GLU THR TYR SEQRES 16 A 614 ILE ASN ASP ILE THR VAL THR ALA ASP ILE ASP PHE THR SEQRES 17 A 614 LYS GLU GLU PRO SER ALA VAL LEU ASN TYR ASN VAL GLU SEQRES 18 A 614 ILE LYS GLY LYS ASP TYR ASN ASN ILE THR CYS LYS VAL SEQRES 19 A 614 GLU LEU PHE ASP GLU GLU GLY THR LYS LEU SER GLU THR SEQRES 20 A 614 GLU GLY SER GLU GLY THR PHE GLU ILE SER ASN VAL ARG SEQRES 21 A 614 LEU TRP GLN PRO LEU ASN ALA TYR LEU TYR LYS ILE LYS SEQRES 22 A 614 VAL THR ALA GLY GLN ASP VAL TYR THR LEU PRO TYR GLY SEQRES 23 A 614 VAL ARG SER VAL ARG VAL ASP GLY THR LYS PHE LEU ILE SEQRES 24 A 614 ASN GLU LYS PRO PHE TYR PHE LYS GLY TYR GLY LYS HIS SEQRES 25 A 614 GLU ASP THR PHE PRO ASN GLY ARG GLY ILE ASN LEU PRO SEQRES 26 A 614 MET ASN THR LYS ASP ILE SER ILE MET LYS TRP GLN HIS SEQRES 27 A 614 ALA ASN SER PHE ARG THR SER HIS TYR PRO TYR SER GLU SEQRES 28 A 614 GLU MET MET ARG LEU CYS ASP GLU GLU GLY ILE VAL VAL SEQRES 29 A 614 ILE ASP GLU THR THR ALA VAL GLY VAL ASN LEU GLN PHE SEQRES 30 A 614 GLY GLY GLY ALA ASN PHE GLY GLY GLU ARG ILE GLY THR SEQRES 31 A 614 PHE ASP LYS GLU HIS GLY VAL GLN THR GLN GLU HIS HIS SEQRES 32 A 614 LYS ASP VAL ILE ARG ASP LEU ILE SER ARG ASP LYS ASN SEQRES 33 A 614 HIS ALA CYS VAL VAL MET TRP SER ILE ALA ASN GLU PRO SEQRES 34 A 614 ASP SER ALA ALA GLU GLY ALA TYR ASP TYR PHE LYS PRO SEQRES 35 A 614 LEU TYR ASP LEU ALA ARG GLU LEU ASP PRO GLN LYS ARG SEQRES 36 A 614 PRO CYS THR LEU VAL SER VAL GLN GLY THR THR ALA ASP SEQRES 37 A 614 THR ASP CYS SER SER GLN LEU SER ASP VAL ILE CYS LEU SEQRES 38 A 614 ASN ARG TYR TYR GLY TRP TYR PHE GLY GLY PRO ASP LEU SEQRES 39 A 614 GLU VAL SER GLU THR GLY LEU ARG LYS GLU LEU SER ASP SEQRES 40 A 614 TRP GLY LYS LEU GLY LYS PRO VAL MET PHE THR GLU TYR SEQRES 41 A 614 GLY ALA ASP THR VAL SER GLY LEU HIS ASP THR THR SER SEQRES 42 A 614 VAL MET TYR THR GLU GLU TYR GLN VAL GLU TYR TYR GLU SEQRES 43 A 614 MET ASN ASN LYS VAL PHE ASP GLU PHE ASP PHE VAL VAL SEQRES 44 A 614 GLY GLU GLN ALA TRP ASN PHE ALA ASP PHE ALA THR SER SEQRES 45 A 614 GLN SER LEU LEU ARG VAL GLN GLY ASN LYS LYS GLY LEU SEQRES 46 A 614 PHE THR ARG ASP ARG LYS PRO LYS MET VAL ALA HIS TYR SEQRES 47 A 614 PHE ARG ASN ARG TRP SER ALA ILE PRO GLU PHE GLY TYR SEQRES 48 A 614 LYS THR LYS HET I9G A 701 73 HETNAM I9G 8-(4-BETA-D-GLUCOPYRANURONOSYLPIPERAZIN-1-YL)-5- HETNAM 2 I9G (MORPHOLIN-4-YL)-1,2,3,4-TETRAHYDRO[1,2,3]TRIAZINO[4', HETNAM 3 I9G 5':4,5]THIENO[2,3 -C]ISOQUINOLINE HETSYN I9G UNC10201652-GLUCURONIC ACID CONJUGATE FORMUL 2 I9G C26 H33 N7 O7 S HELIX 1 AA1 SER A 49 LEU A 53 5 5 HELIX 2 AA2 GLY A 56 ASP A 61 1 6 HELIX 3 AA3 PRO A 75 LYS A 79 5 5 HELIX 4 AA4 ASN A 320 HIS A 335 1 16 HELIX 5 AA5 SER A 347 GLY A 358 1 12 HELIX 6 AA6 THR A 396 LYS A 412 1 17 HELIX 7 AA7 GLY A 432 ASP A 448 1 17 HELIX 8 AA8 CYS A 468 SER A 473 1 6 HELIX 9 AA9 ASP A 490 LYS A 507 1 18 HELIX 10 AB1 THR A 534 ASP A 550 1 17 HELIX 11 AB2 LYS A 590 ALA A 602 1 13 SHEET 1 AA1 4 SER A 13 ASP A 14 0 SHEET 2 AA1 4 VAL A 183 TYR A 186 -1 O ILE A 185 N SER A 13 SHEET 3 AA1 4 VAL A 84 CYS A 87 -1 N VAL A 84 O TYR A 186 SHEET 4 AA1 4 PHE A 113 GLU A 116 -1 O PHE A 113 N CYS A 87 SHEET 1 AA2 6 ASP A 42 PRO A 45 0 SHEET 2 AA2 6 VAL A 18 LEU A 23 -1 N PHE A 21 O ASP A 42 SHEET 3 AA2 6 TRP A 65 ILE A 72 -1 O PHE A 67 N LYS A 22 SHEET 4 AA2 6 ASN A 126 ASN A 133 -1 O ILE A 130 N TYR A 68 SHEET 5 AA2 6 TYR A 93 LEU A 98 -1 N MET A 95 O ALA A 131 SHEET 6 AA2 6 LYS A 101 LYS A 107 -1 O ILE A 103 N ILE A 96 SHEET 1 AA3 2 ILE A 193 ASP A 195 0 SHEET 2 AA3 2 GLU A 218 ILE A 219 -1 O GLU A 218 N ASN A 194 SHEET 1 AA4 3 THR A 199 ASP A 203 0 SHEET 2 AA4 3 SER A 210 ASN A 214 -1 O ASN A 214 N THR A 199 SHEET 3 AA4 3 THR A 250 GLU A 252 -1 O PHE A 251 N LEU A 213 SHEET 1 AA5 4 SER A 242 GLU A 243 0 SHEET 2 AA5 4 GLU A 232 LEU A 233 -1 N LEU A 233 O SER A 242 SHEET 3 AA5 4 TYR A 267 ALA A 273 -1 O LYS A 270 N GLU A 232 SHEET 4 AA5 4 ASP A 276 TYR A 282 -1 O TYR A 282 N TYR A 267 SHEET 1 AA6 3 VAL A 287 VAL A 289 0 SHEET 2 AA6 3 PHE A 294 ILE A 296 -1 O LEU A 295 N ARG A 288 SHEET 3 AA6 3 LYS A 299 PRO A 300 -1 O LYS A 299 N ILE A 296 SHEET 1 AA7 9 PHE A 303 GLY A 307 0 SHEET 2 AA7 9 SER A 338 ARG A 340 1 N SER A 338 O LYS A 304 SHEET 3 AA7 9 VAL A 360 GLU A 364 1 O ILE A 362 N PHE A 339 SHEET 4 AA7 9 VAL A 417 ASN A 424 1 O SER A 421 N ASP A 363 SHEET 5 AA7 9 CYS A 454 SER A 458 1 O THR A 455 N TRP A 420 SHEET 6 AA7 9 ILE A 476 ASN A 479 1 O CYS A 477 N SER A 458 SHEET 7 AA7 9 VAL A 512 GLU A 516 1 O MET A 513 N ILE A 476 SHEET 8 AA7 9 VAL A 555 TRP A 561 1 O GLN A 559 N PHE A 514 SHEET 9 AA7 9 PHE A 303 GLY A 307 1 N PHE A 303 O GLU A 558 CISPEP 1 VAL A 46 PRO A 47 0 3.44 CISPEP 2 LEU A 141 PRO A 142 0 6.98 CISPEP 3 PHE A 313 PRO A 314 0 -2.09 CISPEP 4 GLY A 488 PRO A 489 0 6.30 CISPEP 5 TRP A 561 ASN A 562 0 0.77 CRYST1 180.304 180.304 133.566 90.00 90.00 120.00 P 64 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005546 0.003202 0.000000 0.00000 SCALE2 0.000000 0.006404 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007487 0.00000